+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hereditary Testing Market Research Report by Disease Type, Technology, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 230 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5306608
UP TO OFF until Dec 31st 2022
The Global Hereditary Testing Market size was estimated at USD 4,423.45 million in 2021, USD 4,772.55 million in 2022, and is projected to grow at a CAGR 8.06% to reach USD 7,046.44 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hereditary Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease Type, the market was studied across Hereditary Cancer Testing, Hereditary Non-cancer Testing, Newborn Genetic Screening, Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests, and Preimplantation Genetic Diagnosis & Screening. The Hereditary Cancer Testing is further studied across Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Sarcoma, Stomach/Gastric Cancer, and Uterine Cancer. The Hereditary Non-cancer Testing is further studied across Genetic Tests. The Genetic Tests is further studied across Cardiac Diseases, Other Diseases, and Rare Diseases.
  • Based on Technology, the market was studied across Biochemical, Cytogenetic, and Molecular Testing.
  • Based on Application, the market was studied across Cancer Diagnosis, Cardiovascular Disease Diagnosis, Genetic Disease Diagnosis, and Others.
  • Based on End-User, the market was studied across Clinics, Hospitals, and Others.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hereditary Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hereditary Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hereditary Testing Market, including 23andMe, Inc., Abbott Laboratories, Agilent Technologies, Inc., Beijing Genomics Institute, Bio-Helix Co. Ltd, Bio-Rad Laboratories, Inc., Biocartis Group NV, CENTOGENE N.V., CooperSurgical, Inc., CSL Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc., Igenomix, Illumina, Inc., Invitae Corporation, Konica Minolta, Inc., Laboratory Corporation of America Holdings, Medgenome, Myriad Genetics, Inc, Natera Inc, Pacific Biosciences of California, Inc., Pathway Genomics Corporation, PerkinElmer, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sophia Genetics, Thermo Fisher Scientific, Inc., and Twist Bioscience.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Hereditary Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hereditary Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hereditary Testing Market?
4. What is the competitive strategic window for opportunities in the Global Hereditary Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Hereditary Testing Market?
6. What is the market share of the leading vendors in the Global Hereditary Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Hereditary Testing Market?
Frequently Asked Questions about the Global Hereditary Testing Market

What is the estimated value of the Global Hereditary Testing Market?

The Global Hereditary Testing Market was estimated to be valued at $4423.45 Million in 2021.

What is the growth rate of the Global Hereditary Testing Market?

The growth rate of the Global Hereditary Testing Market is 8.0%, with an estimated value of $7046.44 Million by 2027.

What is the forecasted size of the Global Hereditary Testing Market?

The Global Hereditary Testing Market is estimated to be worth $7046.44 Million by 2027.

Who are the key companies in the Global Hereditary Testing Market?

Key companies in the Global Hereditary Testing Market include 23andMe, Inc., Abbott Laboratories, Agilent Technologies, Inc., Beijing Genomics Institute, Bio, Helix Co. Ltd, Bio, Rad Laboratories, Inc. and CENTOGENE N.V..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Exploration for changes or variants, in DNA to find root cause of potential disease
5.1.1.2. Increased screening by pregnant women
5.1.2. Restraints
5.1.2.1. Limited reimbursement policies
5.1.3. Opportunities
5.1.3.1. Collaborative product development
5.1.3.2. R&D on advance Genome sequencing
5.1.3.3. Attractive investment and amalgamation activity within value chain
5.1.4. Challenges
5.1.4.1. Uncertain outcomes
5.2. Cumulative Impact of COVID-19
6. Hereditary Testing Market, by Disease Type
6.1. Introduction
6.2. Hereditary Cancer Testing
6.2.1. Breast Cancer
6.2.2. Cervical Cancer
6.2.3. Colorectal Cancer
6.2.4. Lung Cancer
6.2.5. Melanoma
6.2.6. Ovarian Cancer
6.2.7. Pancreatic Cancer
6.2.8. Prostate Cancer
6.2.9. Sarcoma
6.2.10. Stomach/Gastric Cancer
6.2.11. Uterine Cancer
6.3. Hereditary Non-cancer Testing
6.3.1. Genetic Tests
6.3.1.1. Cardiac Diseases
6.3.1.2. Other Diseases
6.3.1.3. Rare Diseases
6.4. Newborn Genetic Screening
6.5. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
6.6. Preimplantation Genetic Diagnosis & Screening
7. Hereditary Testing Market, by Technology
7.1. Introduction
7.2. Biochemical
7.3. Cytogenetic
7.4. Molecular Testing
8. Hereditary Testing Market, by Application
8.1. Introduction
8.2. Cancer Diagnosis
8.3. Cardiovascular Disease Diagnosis
8.4. Genetic Disease Diagnosis
8.5. Others
9. Hereditary Testing Market, by End-User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
9.4. Others
10. Americas Hereditary Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Hereditary Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Hereditary Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 23andMe, Inc.
14.2. Abbott Laboratories
14.3. Agilent Technologies, Inc.
14.4. Beijing Genomics Institute
14.5. Bio-Helix Co. Ltd
14.6. Bio-Rad Laboratories, Inc.
14.7. Biocartis Group NV
14.8. CENTOGENE N.V.
14.9. CooperSurgical, Inc.
14.10. CSL Ltd.
14.11. Eurofins Scientific SE
14.12. F. Hoffmann-La Roche Ltd
14.13. Fulgent Genetics, Inc.
14.14. Igenomix
14.15. Illumina, Inc.
14.16. Invitae Corporation
14.17. Konica Minolta, Inc.
14.18. Laboratory Corporation of America Holdings
14.19. Medgenome
14.20. Myriad Genetics, Inc
14.21. Natera Inc
14.22. Pacific Biosciences of California, Inc.
14.23. Pathway Genomics Corporation
14.24. PerkinElmer, Inc.
14.25. Quest Diagnostics Incorporated
14.26. Siemens Healthineers AG
14.27. Sophia Genetics
14.28. Thermo Fisher Scientific, Inc.
14.29. Twist Bioscience
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HEREDITARY TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HEREDITARY TESTING MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL HEREDITARY TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HEREDITARY TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEREDITARY TESTING MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL HEREDITARY TESTING MARKET DYNAMICS
FIGURE 8. GLOBAL HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2027
FIGURE 11. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL HEREDITARY TESTING MARKET SIZE, BY MELANOMA, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL HEREDITARY TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL HEREDITARY TESTING MARKET SIZE, BY SARCOMA, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL HEREDITARY TESTING MARKET SIZE, BY SARCOMA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 52. GLOBAL HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 54. GLOBAL HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 61. GLOBAL HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2027
FIGURE 63. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, 2019-2027 (USD MILLION)
FIGURE 64. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 65. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, 2019-2027 (USD MILLION)
FIGURE 66. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 67. GLOBAL HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, 2019-2027 (USD MILLION)
FIGURE 68. GLOBAL HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 69. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHERS, 2019-2027 (USD MILLION)
FIGURE 70. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 71. GLOBAL HEREDITARY TESTING MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 72. GLOBAL HEREDITARY TESTING MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEREDITARY TESTING MARKET SIZE, BY END-USER, 2027
FIGURE 74. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
FIGURE 75. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 76. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 77. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 78. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHERS, 2019-2027 (USD MILLION)
FIGURE 79. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 80. AMERICAS HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. AMERICAS HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 82. AMERICAS HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 83. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2027
FIGURE 84. ARGENTINA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. BRAZIL HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. CANADA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. MEXICO HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. UNITED STATES HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 90. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 91. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEREDITARY TESTING MARKET SIZE, BY STATE, 2027
FIGURE 92. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 94. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 95. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2027
FIGURE 96. AUSTRALIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 97. CHINA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. INDIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. INDONESIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. JAPAN HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. MALAYSIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. PHILIPPINES HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. SINGAPORE HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. SOUTH KOREA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. TAIWAN HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. THAILAND HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 109. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 110. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2027
FIGURE 111. FRANCE HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 112. GERMANY HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 113. ITALY HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 114. NETHERLANDS HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 115. QATAR HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 116. RUSSIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 117. SAUDI ARABIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 118. SOUTH AFRICA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 119. SPAIN HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 120. UNITED ARAB EMIRATES HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 121. UNITED KINGDOM HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 122. GLOBAL HEREDITARY TESTING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 123. GLOBAL HEREDITARY TESTING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 124. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEREDITARY TESTING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL HEREDITARY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL HEREDITARY TESTING MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY HEREDITARY CANCER TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL HEREDITARY TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS HEREDITARY TESTING MARKET SIZE, BY MELANOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY MELANOMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY MELANOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY MELANOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY OVARIAN CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL HEREDITARY TESTING MARKET SIZE, BY SARCOMA, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS HEREDITARY TESTING MARKET SIZE, BY SARCOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY SARCOMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY SARCOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY SARCOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY STOMACH/GASTRIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY UTERINE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY HEREDITARY NON-CANCER TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY CARDIAC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY OTHER DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, BY REGION, 2019-2027 (USD MILLION)
TABLE 92. AMERICAS HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, BY STATE, 2019-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY NEWBORN GENETIC SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. GLOBAL HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 97. AMERICAS HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING (NIPT) & CARRIER SCREENING TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. GLOBAL HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, BY REGION, 2019-2027 (USD MILLION)
TABLE 102. AMERICAS HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, BY STATE, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS & SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. GLOBAL HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 107. GLOBAL HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 108. AMERICAS HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 110. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY BIOCHEMICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 113. AMERICAS HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 115. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY CYTOGENETIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 118. AMERICAS HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY MOLECULAR TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. GLOBAL HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 123. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 124. AMERICAS HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 125. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 126. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 128. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 129. AMERICAS HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 131. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 133. GLOBAL HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 134. AMERICAS HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 136. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY GENETIC DISEASE DIAGNOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 138. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 139. AMERICAS HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 140. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 141. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 143. GLOBAL HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 144. GLOBAL HEREDITARY TESTING MARKET SIZE, BY CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 145. AMERICAS HEREDITARY TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 146. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 147. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 149. GLOBAL HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 150. AMERICAS HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 151. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 152. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 154. GLOBAL HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 155. AMERICAS HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 156. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 157. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 159. AMERICAS HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 160. AMERICAS HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 161. AMERICAS HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 162. AMERICAS HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 163. AMERICAS HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 164. AMERICAS HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 165. ARGENTINA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. ARGENTINA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 167. ARGENTINA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 168. ARGENTINA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 169. ARGENTINA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 170. BRAZIL HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. BRAZIL HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 172. BRAZIL HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 173. BRAZIL HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 174. BRAZIL HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 175. CANADA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 176. CANADA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 177. CANADA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 178. CANADA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 179. CANADA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 180. MEXICO HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 181. MEXICO HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 182. MEXICO HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 183. MEXICO HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 184. MEXICO HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 185. UNITED STATES HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 187. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 188. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 189. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 190. UNITED STATES HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 191. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 192. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 193. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 194. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 195. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 196. ASIA-PACIFIC HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 197. AUSTRALIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 198. AUSTRALIA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 199. AUSTRALIA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 200. AUSTRALIA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 201. AUSTRALIA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 202. CHINA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 203. CHINA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 204. CHINA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 205. CHINA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 206. CHINA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 207. INDIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 208. INDIA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 209. INDIA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 210. INDIA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 211. INDIA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 212. INDONESIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 213. INDONESIA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 214. INDONESIA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 215. INDONESIA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 216. INDONESIA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 217. JAPAN HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 218. JAPAN HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 219. JAPAN HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 220. JAPAN HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 221. JAPAN HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 222. MALAYSIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 223. MALAYSIA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 224. MALAYSIA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 225. MALAYSIA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 226. MALAYSIA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 227. PHILIPPINES HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 228. PHILIPPINES HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 229. PHILIPPINES HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 230. PHILIPPINES HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 231. PHILIPPINES HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 232. SINGAPORE HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 233. SINGAPORE HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 234. SINGAPORE HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 235. SINGAPORE HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 236. SINGAPORE HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 237. SOUTH KOREA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 238. SOUTH KOREA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 239. SOUTH KOREA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 240. SOUTH KOREA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 241. SOUTH KOREA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 242. TAIWAN HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 243. TAIWAN HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 244. TAIWAN HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 245. TAIWAN HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 246. TAIWAN HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 247. THAILAND HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 248. THAILAND HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 249. THAILAND HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 250. THAILAND HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 251. THAILAND HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 258. FRANCE HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 259. FRANCE HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 260. FRANCE HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 261. FRANCE HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 262. FRANCE HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 263. GERMANY HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. GERMANY HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 265. GERMANY HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 266. GERMANY HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 267. GERMANY HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 268. ITALY HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 269. ITALY HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 270. ITALY HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 271. ITALY HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 272. ITALY HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 273. NETHERLANDS HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 274. NETHERLANDS HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 275. NETHERLANDS HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 276. NETHERLANDS HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 277. NETHERLANDS HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 278. QATAR HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 279. QATAR HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 280. QATAR HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 281. QATAR HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 282. QATAR HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 283. RUSSIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 284. RUSSIA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 285. RUSSIA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 286. RUSSIA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 287. RUSSIA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 288. SAUDI ARABIA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 289. SAUDI ARABIA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 290. SAUDI ARABIA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 291. SAUDI ARABIA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 292. SAUDI ARABIA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 293. SOUTH AFRICA HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 294. SOUTH AFRICA HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 295. SOUTH AFRICA HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 296. SOUTH AFRICA HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 297. SOUTH AFRICA HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 298. SPAIN HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 299. SPAIN HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 300. SPAIN HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 301. SPAIN HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 302. SPAIN HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 308. UNITED KINGDOM HEREDITARY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 309. UNITED KINGDOM HEREDITARY TESTING MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 310. UNITED KINGDOM HEREDITARY TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 311. UNITED KINGDOM HEREDITARY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 312. UNITED KINGDOM HEREDITARY TESTING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 313. GLOBAL HEREDITARY TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 314. GLOBAL HEREDITARY TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 315. GLOBAL HEREDITARY TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 316. GLOBAL HEREDITARY TESTING MARKET RANKING
TABLE 317. GLOBAL HEREDITARY TESTING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 318. GLOBAL HEREDITARY TESTING MARKET MERGER & ACQUISITION
TABLE 319. GLOBAL HEREDITARY TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 320. GLOBAL HEREDITARY TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 321. GLOBAL HEREDITARY TESTING MARKET INVESTMENT & FUNDING
TABLE 322. GLOBAL HEREDITARY TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 323. GLOBAL HEREDITARY TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • 23andMe, Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beijing Genomics Institute
  • Bio-Helix Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Biocartis Group NV
  • CENTOGENE N.V.
  • CooperSurgical, Inc.
  • CSL Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Fulgent Genetics, Inc.
  • Igenomix
  • Illumina, Inc.
  • Invitae Corporation
  • Konica Minolta, Inc.
  • Laboratory Corporation of America Holdings
  • Medgenome
  • Myriad Genetics, Inc
  • Natera Inc
  • Pacific Biosciences of California, Inc.
  • Pathway Genomics Corporation
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Sophia Genetics
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience

Methodology

Loading
LOADING...